3-[(6-Arylamino)pyridazinylamino]benzoic acids: design, synthesis and in vitro evaluation of anticancer activity

Khaled A M Abouzid; Khalil, Nadia A; Ahmed, Eman M; Mohamed, Khaled Omar;

Abstract


A series of novel substituted 3,6-disubstituted pyridazines based on the structure of vatalanib (PTK787) were designed and synthesized. The cytotoxicity of the final compounds was tested in vitro on HT-29 colon cancer cell line. Compounds 2a and 2b with 4-chlorophenylamino moiety, exerted the highest cytotoxic activity with IC(50) values equal to 15.3 and 3.9 μM respectively. The most promising compound, 2b, was found to be about fivefold more active than vatalanib against HT-29 colon cancer cell line.


Other data

Title 3-[(6-Arylamino)pyridazinylamino]benzoic acids: design, synthesis and in vitro evaluation of anticancer activity
Authors Khaled A M Abouzid ; Khalil, Nadia A; Ahmed, Eman M; Mohamed, Khaled Omar
Keywords Pyridazine;Colon cancer;Vatalanib;cytotoxicity;ENDOTHELIAL GROWTH-FACTOR;PYRIDAZINE DERIVATIVES;ANGIOGENESIS;INHIBITORS;RECEPTORS
Issue Date Jan-2013
Publisher PHARMACEUTICAL SOC KOREA
Journal Archives of pharmacal research 
Volume 36
Start page 41
End page 50
ISSN 0253-6269
DOI 10.1007/s12272-013-0007-8
PubMed ID 23307426
Scopus ID 2-s2.0-84873702831
Web of science ID WOS:000314719600004

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

Citations 3 in pubmed
Citations 14 in scopus


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.